Activated T lymphocyte(Immuncell-LC): Clinical Trials

1 trial of Activated T lymphocyte(Immuncell-LC), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Activated T lymphocyte(Immuncell-LC): new trials by email Literature Review of Activated T lymphocyte(Immuncell-LC) trials Research Report on Activated T lymphocyte(Immuncell-LC)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial to Assess the Efficacy and Safety of 'Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea
Activated T lymphocyte(Immuncell-LC) - Glioblastoma
Phase 3CompletedGC Cell Corporation1802008-12-052025-10-10

Conditions studied

Glioblastoma (1)

Sponsors

GC Cell Corporation (1)

Countries

South Korea (1)

Top investigators

Chunghyun Kim, MD (1)